title: A new tumor promotion pathway and its inhibitors.
abstract: Tumor promotion is a critical point in multistage carcinogenesis in humans. We have identified a common biochemical and molecular tumor promotion mechanism, the okadaic acid pathway, applicable in various organs. Tumor promotion by the okadaic acid class of compounds is mediated through inhibition of protein phosphatases 1 and 2A, resulting in an increase of protein phosphorylation and a subsequent expression of cell proliferation genes. Recently, we demonstrated that okadaic acid induced the release of mouse tumor necrosis factor-alpha (mTNF-alpha) from BALB/3T3 cells. The first part of this review discusses the link between the okadaic acid pathway and TNF-alpha as endogenous tumor promoters in vivo. Inhibitors of tumor promotion are varied. For the purpose of cancer chemoprevention in humans, the inhibitors sarcophytol A, canventol, and (-)-epigallocatechin gallate (EGCG) were studied and the results are presented. The inhibitory mechanisms also were varied: sarcophytol A inhibited H2O2 formation by TPA-activated human polymorphonuclear leukocytes; canventol inhibited protein isoprenylation in the cells; and EGCG, which is a main constituent of Japanese green tea, is an antioxidant. These inhibitors are promising cancer chemopreventive agents. Study of the essential tumor promotion mechanisms will facilitate the development of cancer chemopreventive agents.
authors.affiliation: Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Fujiki
authors.forename: M
authors.initials: M
authors.lastname: Suganuma
authors.forename: A
authors.initials: A
authors.lastname: Komori
authors.forename: J
authors.initials: J
authors.lastname: Yatsunami
authors.forename: S
authors.initials: S
authors.lastname: Okabe
authors.forename: T
authors.initials: T
authors.lastname: Ohta
authors.forename: E
authors.initials: E
authors.lastname: Sueoka
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D003511:Cyclohexanols / Q000494:pharmacology*; D004224:Diterpenes / Q000494:pharmacology*; D004988:Ethers, Cyclic / Q000633:toxicity; D006801:Humans; D009369:Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D019319:Okadaic Acid; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D016588:Anticarcinogenic Agents; D003511:Cyclohexanols; D004224:Diterpenes; D004988:Ethers, Cyclic; D014409:Tumor Necrosis Factor-alpha; C082453:canventol; D019319:Okadaic Acid; C058761:sarcophytol A; D002392:Catechin; C045651:epigallocatechin gallate